Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1971532 · TELO

Telomir Pharmaceuticals, Inc.

Filing with the SEC SEC-reporting company Miami, FL Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Jan 12, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Net loss in 2025Net loss of $10.4M for the year (2024: −$16.5M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$10.4M−$16.5M
Total assets$7.3M$1.3M
Total liabilities$1.4M$681K
Stockholders’ equity$5.9M$643K
Cash and equivalents$7.3M$1.3M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Telomir Pharmaceuticals, Inc.
CIK
0001971532
Tickers
TELO
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company
Status
Filing with the SEC
State of incorporation
Florida
Business address
Miami, Florida
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 6, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 6, 2026 · filing · edition of Nov 6, 2026
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jun 8, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 9.01 · filed Apr 24, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 5.07, 9.01 · filed Mar 27, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 17, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 12, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 22, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Nov 20, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 10, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 9.01 · filed May 21, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 14, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Feb 4, 2025 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Dec 20, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 21, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 13, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jun 24, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 13, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Apr 12, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 29, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Feb 12, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Nov 14, 2023 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Apr 3, 2023 · filing